コロラド州における小細胞肺がんの臨床試験
コロラド州内の拠点で、小細胞肺がんに関する16件の研究が参加者を募集しています。
コロラド州内の都市
公式研究テキスト（英語）
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Rocky Mountain Cancer Center, Denver
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/10/02更新 · NCT04585750A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- SCRI at HealthOne, Denver
被験者募集中第1相
19歳以上 · 全性別 · 2026/10/01更新 · NCT06586957Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- University of Colorado Cancer Center, Aurora
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/21更新 · NCT05983432A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
- University of Colorado, Aurora
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/14更新 · NCT07218146A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
- University of Colorado Anschutz Medical Campus ( Site 1110), Aurora
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/09更新 · NCT06780137AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
- Avenzo Therapeutics Recruiting Site, Denver
被験者募集中第1/2相
18歳〜75歳 · 全性別 · 2026/09/04更新 · NCT07038343A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
- University of Colorado Cancer Center, Aurora
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/26更新 · NCT06892548A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
- Rocky Mountain Cancer Centers, Lone Tree
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/17更新 · NCT06095505A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- University of Colorado Hospital - Anschutz Cancer Pavilion (ACP), Aurora
- University of Colorado Hospital, Aurora
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/22更新 · NCT06131840A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
- Sarah Cannon Research Institute at HealthONE, Denver
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/15更新 · NCT05652686A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
- Sarah Cannon Research Institute at HealthONE, Denver
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/09更新 · NCT07174583Tempus Small Cell Lung Cancer Observational Study (Sculptor)
- University of Colorado, Aurora
被験者募集中観察研究
18歳以上 · 全性別 · 2026/06/15更新 · NCT05257551Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
- UCHealth University of Colorado Hospital, Aurora
- UCHealth Memorial Hospital Central, Colorado Springs
- Memorial Hospital North, Colorado Springs
- 他5件
被験者募集中第2相
18歳以上 · 全性別 · 2026/03/30更新 · NCT06769126Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
- Sarah Cannon Research Institute at HealthONE, Denver
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/02/18更新 · NCT07030257Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
- University of Colorado Cancer Center at UC Health Sciences Center, Aurora
被験者募集中観察研究
21歳〜90歳 · 全性別 · 2025/09/22更新 · NCT00900419ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。